Privia Health (PRVA) Liabilities and Shareholders Equity (2020 - 2026)

Privia Health's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 19.8% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $5.4 billion, a 19.11% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 20.57% from the prior year.
• Liabilities and Shareholders Equity advanced to $1.4 billion in Q1 2026 per PRVA's latest filing, from $1.4 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $1.4 billion in Q1 2026 and bottomed at $723.2 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $1.0 billion (2024), against an average of $1.1 billion.
• Across the five-year window, Liabilities and Shareholders Equity jumped 107.65% in 2022 and gained 13.59% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $792.8 million in 2022, then gained by 26.12% to $999.9 million in 2023, then climbed by 13.59% to $1.1 billion in 2024, then grew by 20.57% to $1.4 billion in 2025, then increased by 3.54% to $1.4 billion in 2026.
• Per Business Quant, the three latest PRVA Liabilities and Shareholders Equity figures stand at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025).